Shreya Agrawal: Integrated Risk Scores for Thrombosis and Bleeding
Shreya Agrawal, Consultant Hematologist and Bone marrow transplant physician at S. L. Raheja Hospital – A Fortis Associate, shared a post on LinkedIn:
“In hematology and cardiology practice, risk stratification is everything.
We often talk about thrombosis and bleeding as separate problems — but in reality, they coexist in a delicate balance.
The real art lies in identifying who needs prolonged anticoagulation, who needs dual antiplatelet therapy, and who is at high bleeding risk.
There are several validated tools that help us move from instinct-based decisions to evidence-based precision:
- VTE recurrence after anticoagulation – Vienna, HERDOO2
- Bleeding risk on OAC – VTE-BLEED, CHAP
- Post-PCI risk stratification – DAPT score, PRECISE-DAPT
- PAD and cardiovascular risk – OAC3-PAD, SMART
- Diabetes and 10-year CV risk – SCORE2
Each tool incorporates clinical variables we routinely assess — age, renal function, hemoglobin, prior bleeding, inflammatory markers, comorbidities — but converts them into structured decision support.
Why this matters:
- Avoid unnecessary prolonged anticoagulation
- Identify patients who truly benefit from extended therapy
- Reduce preventable bleeding
- Personalize cardiovascular prevention
As we move toward precision medicine, structured risk calculators are no longer optional — they’re essential.
Curious to know — how many of these scores are you actively using in daily practice?”
Stay updated with Hemostasis Today.
-
Feb 28, 2026, 15:02Stéphanie Forté: Advancing Stroke Prevention in Adults With Sickle Cell Disease Through Transcranial Doppler
-
Feb 28, 2026, 14:52Jonathan Douxfils: Are All Progestin-Only Contraceptives Truly ‘Neutral’ for VTE Risk?
-
Feb 28, 2026, 14:48WFH Acknowledges BioMarin’s Decision to Discontinue ROCTAVIAN
-
Feb 28, 2026, 14:43Fabrice Cognasse: Honored to Contribute to New Reference Work on Platelets in Disease
-
Feb 28, 2026, 14:36Shadi Tabibian: Global Trends in Prenatal Diagnosis of Hemophilia A and B Over Two Decades
-
Feb 28, 2026, 14:14Omar Adwan։ ESR in Inflammation and Disease Assessment
-
Feb 28, 2026, 12:56Sinju Thomas: Presenting Gene Therapy Collection Challenges at the Apheresis Hub Conference 2026
-
Feb 28, 2026, 12:54Mahesan Subramaniam: Supporting Circulation and Managing Cholesterol Protects Heart and Brain
-
Feb 28, 2026, 12:09Gonzalo Montero Martin: A Breakthrough in HLA Nomenclature for Transplant Evaluation